Good results for the treatment of schizophrenia with a cannabis-based drug
British firm GW Pharmaceuticals Plc has developed an experimental drug that has shown better results than a placebo in the treatment of schizophrenia. The clinical trial is currently in its mid-stage. The drug, called cannabidiol, has been administered to 88 patients with...